(Q43990635)

28 November 2017

title

Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults (English)

1 reference

28 November 2017

0 references

0 references

1

1 reference

28 November 2017

Earl S Ford

2

1 reference

28 November 2017

Guixiang Zhao

3

1 reference

28 November 2017

Chaoyang Li

4

1 reference

28 November 2017

Kurt J Greenlund

5

1 reference

28 November 2017

Janet B Croft

6

1 reference

28 November 2017

publication date

28 May 2011

1 reference

Journal of Behavioral Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

35

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

200-210

1 reference

https://scigraph.springernature.com/pub.10.1007/s10865-011-9353-5

28 November 2017

exact match

0 references

cites work

Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Drinking patterns and body mass index in never smokers: National Health Interview Survey, 1997-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Traditional markers of excessive alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Obesity as a disease: no lightweight matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Alcoholic liver disease: dose and threshold--new thoughts on an old topic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Behavior therapy and cognitive-behavioral therapy of obesity: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Review article: alcoholic liver disease--pathophysiological aspects and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Secular trends in cardiovascular disease risk factors according to body mass index in US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Inconsistent report of pre-pregnancy-recognition alcohol use by Latinas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Transtheoretical model-based multiple behavior intervention for weight management: effectiveness on a population basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Serum aminotransferase activity and mortality risk in a United States community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Estimates of body composition with dual-energy X-ray absorptiometry in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Gamma-glutamyl transferase: a novel cardiovascular risk biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Cardiovascular and metabolic effects of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Poor health is associated with episodic heavy alcohol use: evidence from a National Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Evaluation of abnormal liver-enzyme results in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Biochemical detection and monitoring of alcohol abuse and abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Under-reporting of alcohol consumption in household surveys: a comparison of quantity-frequency, graduated-frequency and recent recall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Differential effects of alcohol drinking pattern on liver enzymes in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Alcohol drinking pattern and subjective health in a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

From herbal roots to synthetic medicines: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Multiple healthy behaviors and optimal self-rated health: findings from the 2007 Behavioral Risk Factor Surveillance System Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Alcohol and self-rated health in a Mediterranean country: the role of average volume, drinking pattern, and alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

The Treatment of Obesity and Its Co-occurrence with Substance Use Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

The public health impact of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Weight control behaviors in overweight/obese U.S. adults with diagnosed hypertension and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

The epidemiology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Transforming Research Strategies for Understanding and Preventing Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Is alcohol consumption good for you? Results from the 2005 Canadian Community Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9353-5

Hepatic complications of obesity

21 January 2018

1 reference

12 December 2020

Trends in obesity and abdominal obesity among adults in the United States from 1999-2008.

1 reference

12 December 2020

Screening for obesity in adults: recommendations and rationale.

1 reference

12 December 2020

Gender differences in the relationship between alcohol consumption and drink problems are largely accounted for by body water

1 reference

12 December 2020

The economic impact of obesity in the United States

1 reference

12 December 2020

Serious psychological distress and its associations with body mass index: findings from the 2007 Behavioral Risk Factor Surveillance System.

1 reference

12 December 2020

1 reference

12 December 2020

Behavioral treatment of obesity

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

Biomarkers for alcohol use and abuse--a summary

1 reference

12 December 2020

Diagnosis and treatment of obesity in adults: an applied evidence-based review.

1 reference

12 December 2020

Surveillance for acute viral hepatitis - United States, 2007.

1 reference

12 December 2020

Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index

1 reference

12 December 2020

Mildly elevated liver transaminase levels in the asymptomatic patient.

1 reference

12 December 2020

Binge drinking and suboptimal self-rated health among adult drinkers

1 reference

12 December 2020

Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States

1 reference

12 December 2020

Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase activity

1 reference

12 December 2020

Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease

1 reference

12 December 2020

10.1007/S10865-011-9353-5

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1028408969

0 references

1 reference